[Federal Register Volume 74, Number 241 (Thursday, December 17, 2009)]
[Notices]
[Pages 66976-66977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-30014]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-10-0761]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Randomized Controlled Trial of Routine Screening for Intimate 
Partner Violence (OMB No. 0920-0761 Exp. 1/31/2011)--Revision--National 
Center for Injury Prevention and Control (NCIPC), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    Intimate partner violence (IPV) is a prevalent problem with serious 
health consequences that include death, physical injury, increased 
rates of physical illness, posttraumatic stress, increased 
psychological distress, depression, substance abuse, and suicide. Some 
studies suggest that abuse perpetrated by intimate partners tends to be 
repetitive and escalates in severity over time. This research has been 
the basis for promoting early diagnosis and intervention.
    Health care providers appear to be well situated to identify IPV. 
Women come into contact with health care services routinely for a 
number of reasons such as prenatal care, family planning, cancer 
screening, and well baby care. Women experiencing IPV make more visits 
to emergency departments, primary care facilities, and mental health 
agencies than non-abused women. Considering the magnitude and severity 
of IPV, and the potential role health care providers could play in 
reducing its serious consequences, numerous professional and health 
care organizations have recommended routine screening of women for IPV 
in primary care settings. However, various systematic reviews of the 
literature have not found evidence for the effectiveness of screening 
to improve outcomes for women exposed to IPV.
    Based on the recommendations of an expert panel convened, CDC is 
proposing to conduct a randomized controlled trial to provide this 
evidence. The trial will recruit 2675 women in a network of women's 
health clinics. Women attending these clinics tend to be African 
American and of lower socioeconomic status. For this study, women will 
be randomly allocated to one of three arms: (1) Screened for IPV, and 
if disclosing IPV, provided information on available IPV services; (2) 
not screened and all receiving information on available IPV services; 
or (3) a control group that will not be screened nor receive 
information on available IPV services. All three arms will be assessed 
with a self-report measure for disability, quality of life, and 
utilization of health services at baseline utilizing an audio-computer-
assisted structured interview (A-CASI) and at a 12-month follow-up 
utilizing a computerized-assisted telephone interview (CATI). The 
results from this Randomized Controlled Trial, will guide CDC as well 
as other governmental agencies, professional and health care 
organizations, and women's advocate groups in formulating its 
recommendations and policies regarding routine screening. A pretest 
with 196 women in a women's health clinic was conducted to test the 
enrollment, randomization, interview, and follow-up procedures; and 
provide estimates for outcome measures. Based on the results of the 
pretest, CDC has revised the measures, procedures, and sample size 
requirements for the Randomized Controlled Trial. There are no costs to 
respondents other than their time to participate in the survey.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   response  (in   Annual burden
                                                    respondents     respondent        hours)        (in hours)
----------------------------------------------------------------------------------------------------------------
Women Seeking Health Care       Eligibility                   70               1            1/60               2
 Services.                       Script for
                                 Pretest.
                                Baseline                      65               1           15/60              17
                                 Questionnaire
                                 Pretest.
                                Follow-up                     59               1           12/60              12
                                 Questionnaire
                                 Pretest.

[[Page 66977]]

 
                                Eligibility                  668               1            1/60              12
                                 Script for Main
                                 Study.
                                Baseline                     535               1           16/60             143
                                 Questionnaire
                                 Main Study.
                                Follow-up                    356               1           21/60             125
                                 Questionnaire
                                 Main Study
                                 (estimated 30%
                                 lost to follow-
                                 up).
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             311
----------------------------------------------------------------------------------------------------------------


    Dated: December 11, 2009.
Marilyn S. Radke,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. E9-30014 Filed 12-16-09; 8:45 am]
BILLING CODE 4163-18-P